Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


26.06.2017

1 BMC Cancer
1 Br J Cancer
1 Clin Cancer Res
15 Gynecol Oncol
1 Histopathology
1 Int J Cancer
1 Oncogene
2 Oncol Rep
2 Oncology (Williston Park)
1 PLoS One
3 Tumour Biol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. YANG J, Zhou Y, Ng SK, Huang KC, et al
    Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    BMC Cancer. 2017;17:422.
    PubMed     Text format     Abstract available


    Br J Cancer

  2. KOMMOSS S, Gilks CB, du Bois A, Kommoss F, et al
    Ovarian carcinoma diagnosis: the clinical impact of 15 years of change.
    Br J Cancer. 2016 Sep 15. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  3. YANG WL, Gentry-Maharaj A, Simmons AR, Ryan A, et al
    Elevation of TP53 Autoantibody Prior to CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
    Clin Cancer Res. 2017 Jun 21. pii: clincanres.0284.2017.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  4. RASMUSSEN EL, Hannibal CG, Dehlendorff C, Baandrup L, et al
    Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
    Gynecol Oncol. 2017 Jan 17. pii: S0090-8258(17)30039.
    PubMed     Text format     Abstract available

  5. MATSUO K, Machida H, Takiuchi T, Grubbs BH, et al
    Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors.
    Gynecol Oncol. 2017 Jan 26. pii: S0090-8258(17)30063.
    PubMed     Text format     Abstract available

  6. REISS KA, Herman JM, Armstrong D, Zahurak M, et al
    A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian
    Gynecol Oncol. 2017 Jan 18. pii: S0090-8258(17)30060.
    PubMed     Text format     Abstract available

  7. HALTIA UM, Andersson N, Yadav B, Farkkila A, et al
    Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.
    Gynecol Oncol. 2017 Jan 16. pii: S0090-8258(16)31681.
    PubMed     Text format     Abstract available

  8. VON GRUENIGEN VE, Huang HQ, Beumer JH, Lankes HA, et al
    Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Jan 12. pii: S0090-8258(16)31602.
    PubMed     Text format     Abstract available

  9. TUOMI T, Pasanen A, Leminen A, Butzow R, et al
    Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort.
    Gynecol Oncol. 2017 Jan 6. pii: S0090-8258(17)30041.
    PubMed     Text format     Abstract available

  10. GOTTLIEB CE, Mills AM, Cross JV, Ring KL, et al
    Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumors.
    Gynecol Oncol. 2017 Jan 5. pii: S0090-8258(16)31685.
    PubMed     Text format     Abstract available

  11. BUTTARELLI M, Mascilini F, Zannoni GF, Ciucci A, et al
    Hormone receptor expression profile of low-grade serous ovarian cancers.
    Gynecol Oncol. 2017 Feb 20. pii: S0090-8258(17)30150.
    PubMed     Text format     Abstract available

  12. KOMIYAMA S, Manrai M, Takahashi R, Takeya C, et al
    Safe dissection of high paraaortic lymph nodes superior to the renal vein in ovarian, primary peritoneal, or fallopian tube cancer by the "Komiyama's maneuver", a modification of Kocher's maneuver.
    Gynecol Oncol. 2017 Feb 22. pii: S0090-8258(17)30126.
    PubMed     Text format     Abstract available

  13. VAN DE VRIE R, van Meurs HS, Rutten MJ, Naaktgeboren CA, et al
    Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer.
    Gynecol Oncol. 2017 Jun 20. pii: S0090-8258(17)30960.
    PubMed     Text format     Abstract available

  14. SZENDER JB, Emmons T, Belliotti S, Dickson D, et al
    Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study.
    Gynecol Oncol. 2017 Jun 14. pii: S0090-8258(17)30937.
    PubMed     Text format     Abstract available

  15. SCOTT SA, van der Zanden C, Cai E, McGahan CE, et al
    Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
    Gynecol Oncol. 2017 Mar 27. pii: S0090-8258(17)30228.
    PubMed     Text format     Abstract available

  16. JESKE YW, Ali S, Byron SA, Gao F, et al
    FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Mar 14. pii: S0090-8258(17)30152.
    PubMed     Text format     Abstract available

  17. NASIOUDIS D, Kanninen TT, Holcomb K, Sisti G, et al
    Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors.
    Gynecol Oncol. 2017 Mar 11. pii: S0090-8258(17)30205.
    PubMed     Text format     Abstract available

  18. VAN BROEKHOVEN ME, de Rooij BH, Pijnenborg JM, Vos MC, et al
    Illness perceptions and changes in lifestyle following a gynecological cancer diagnosis: A longitudinal analysis.
    Gynecol Oncol. 2017 Mar 6. pii: S0090-8258(17)30157.
    PubMed     Text format     Abstract available


    Histopathology

  19. STEWART CJ, Bowtell DD, Doherty DA, Leung YC, et al
    Long-term survival of patients with mismatch repair protein-deficient, high-stage ovarian clear cell carcinoma.
    Histopathology. 2017;70:309-313.
    PubMed     Text format     Abstract available


    Int J Cancer

  20. JONES NL, Xiu J, Chatterjee-Paer S, Buckley de Meritens A, et al
    Distinct molecular landscapes between endometrioid and non-endometrioid uterine carcinomas.
    Int J Cancer. 2016 Dec 1. doi: 10.1002/ijc.30537.
    PubMed     Text format     Abstract available


    Oncogene

  21. KLYMENKO Y, Kim O, Loughran E, Yang J, et al
    Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  22. CHO SY, Kim K, Park MS, Jang MY, et al
    Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma.
    Oncol Rep. 2017;37:2620-2632.
    PubMed     Text format     Abstract available

  23. QIU S, Sun L, Jin Y, An Q, et al
    Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy.
    Oncol Rep. 2017;38:309-316.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  24. FAGOTTI A, Scambia G
    Counterpoint: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer.
    Oncology (Williston Park). 2017;31:453.
    PubMed     Text format    

  25. COWAN RA, Chi DS
    Point: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer.
    Oncology (Williston Park). 2017;31:453-7.
    PubMed     Text format    


    PLoS One

  26. SIEBENKAS C, Chiappinelli KB, Guzzetta AA, Sharma A, et al
    Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.
    PLoS One. 2017;12:e0179501.
    PubMed     Text format     Abstract available


    Tumour Biol

  27. CHANG L, Guo R, Yuan Z
    IL-36alpha suppresses proliferation of ovarian cancer cells.
    Tumour Biol. 2017;39:1010428317706918.
    PubMed     Text format     Abstract available

  28. LI Q, Xue X, Li W, Wang Q, et al
    Heterogeneous DNA methylation status in same-cell subpopulations of ovarian cancer tissues.
    Tumour Biol. 2017;39:1010428317701650.
    PubMed     Text format     Abstract available

  29. SUN H, Shi JX, Zhang HF, Xing MT, et al
    Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
    Tumour Biol. 2017;39:1010428317699132.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: